This article discusses the different treatment options for Alcaligenes Xylosoxidans.



  1. L. Saiman, Y. Chen, S. Tabibi, P. San Gabriel, J. Zhou, Z. Liu, L. Lai, and S. Whittier, "Identification and Antimicrobial Susceptibility of Alcaligenes xylosoxidans Isolated from Patients with Cystic Fibrosis", Journal of Clinical Microbiology, vol. 39, pp. 3942-3945, 2001. http://dx.doi.org/10.1128/JCM.39.11.3942-3945.2001